1. Corrado, A., Sanpaolo, E. R., Di Bello, S., and Cantatore, F. P. (2017) Osteoblast as a target of anti-osteoporotic treatment. Postgraduate Medicine 129, 858-865
2. Osathanon, T., Nowwarote, N., and Pavasant, P. (2011) Basic fibroblast growth factor inhibits mineralization but induces neuronal differentiation by human dental pulp stem cells through a FGFR and PLCgamma signaling pathway. Journal of Cellular Biochemistry 112, 1807-1816
3. Itoh, N., and Ornitz, D. M. (2008) Functional evolutionary history of the mouse Fgf gene family. Developmental dynamics : an official publication of the American Association of Anatomists 237, 18-27
4. Ornitz, D. M., and Itoh, N. (2015) The Fibroblast Growth Factor signaling pathway. Wiley interdisciplinary reviews. Developmental Biology 4, 215-266
5. Sobue, T., Gravely, T., Hand, A., Min, Y. K., Pilbeam, C., Raisz, L. G., Zhang, X., Larocca, D., Florkiewicz, R., and Hurley, M. M. (2002) Regulation of fibroblast growth factor 2 and fibroblast growth factor receptors by transforming growth factor beta in human osteoblastic MG-63 cells. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 17, 502-512
6. Okamura, H., Yoshida, K., Ochiai, K., and Haneji, T. (2011) Reduction of protein phosphatase 2A Calpha enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix. Bone 49, 368-375
7. Cohen, P. (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58, 453-508
8. Magnusdottir, A., Stenmark, P., Flodin, S., Nyman, T., Kotenyova, T., Graslund, S., Ogg, D., and Nordlund, P. (2009) The structure of the PP2A regulatory subunit B56 gamma: the remaining piece of the PP2A jigsaw puzzle. Proteins 74, 212-221
9. Reiff, D. A., Kelpke, S., Rue, L., 3rd, and Thompson, J. A. (2001) Acidic fibroblast growth factor attenuates the cytotoxic effects of peroxynitrite in primary human osteoblast precursors. The Journal of Trauma 50, 433-438; discussion 439
10. Zhang, H. N., Li, L., Gao, P., Chen, H. Z., Zhang, R., Wei, Y. S., Liu, D. P., and Liang, C. C. (2010) Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochemical and Biophysical Research Communications 397, 569-575
11. Zhang, B., Yan, J., Umbach, A. T., Fakhri, H., Fajol, A., Schmidt, S., Salker, M. S., Chen, H., Alexander, D., Spichtig, D., Daryadel, A., Wagner, C. A., Foller, M., and Lang, F. (2016) NFkappaB-sensitive Orai1 expression in the regulation of FGF23 release. Journal of Molecular Medicine 94, 557-566
12. Ishibashi, K., Ishii, K., Sugiyama, G., Kamata, YU., Suzuki, A., Kumamaru, W., Ohyama, Y., Nakano, H., Kiyoshima, T., Sumida, T., Yamada, T., and Mori Y. (2018) Regulation of β-Catenin Phosphorylation by PR55β in Adenoid Cystic Carcinoma. Cancer Genomics proteomics15, 53-60
13. Muenke, M., Kress, W., Collmann, H., and Solomon, B. (2011) Craniosynostoses : molecular genetics, principles of diagnosis and treatment, Karger, Basel 19, 119-142
14. Yukiho, T., Masahiko, Y., Kenji, H., Kazuya, M., Hideki, N., Toshio, M., PierreJ, M., and Keiji M. (2004) A Soluble Form of Fibroblast Growth Factor Receptor 2 (FGFR2) with S252W Mutation Acts as an Efficient Inhibitor for the Enhanced Osteoblastic Differentiation Caused by FGFR2 Activation in Apert Syndrome. Journal of Biological Chemistry 279, 45926-45934
15. Smits, P. H., Smits, H. L., Minnaar, R. P., Hemmings, B. A., Mayer-Jaekel, R. E., Schuurman, R., van der Noordaa, J., and ter Schegget, J. (1992) The 55 kDa regulatory subunit of protein phosphatase 2A plays a role in the activation of the HPV16 long control region in human cells with a deletion in the short arm of chromosome 11. The EMBO Journal 11, 4601-4606
16. Jing, T., Puay, L., Zhimei, L., Yaw, C., Shing, C., and Qiang, Y. (2010) B55β-Associated PP2A Complex Controls PDK1-Directed Myc Signaling and Modulates Rapamycin Sensitivity in Colorectal Cancer. Cancer Cell18, 459-471
17. Grose, R., and Werner, S. (2004) Wound-healing studies in transgenic and knockout mice. Molecular Biotechnology 28, 147-166
18. Meraw, S. J., Reeve, C. M., Lohse, C. M., and Sioussat, T. M. (2000) Treatment of peri-implant defects with combination growth factor cement. Journal of Periodontology 71, 8-13
19. Beck, C. W., Sutherland, D. J., and Woodland, H. R. (1998) Involvement of NF-kappaB associated proteins in FGF-mediated mesoderm induction. The International Journal of Developmental Biology 42, 67-77
20. Valdes, J. A., Hidalgo, J., Galaz, J. L., Puentes, N., Silva, M., Jaimovich, E., and Carrasco, M. A. (2007) NF-kappaB activation by depolarization of skeletal muscle cells depends on ryanodine and IP3 receptor-mediated calcium signals. American Journal of Physiology- Cell Physiology 292, C1960-1970
21. Yang, J., Fan, G. H., Wadzinski, B. E., Sakurai, H., and Richmond, A. (2001) Protein phosphatase 2A interacts with and directly dephosphorylates RelA. The Journal of Biological Chemistry 276, 47828-47833